Multiple Sclerosis
                                    1 - 15 of
                                43 Results
                        
                        Sort Results:
                                    
                                            Article:
                                            Lemtrada (LEM-trah-dah, alemtuzumab) will be a new IV option for relapsing-remitting forms of multiple sclerosis (MS)
                                            June 2014
                                        
                                        
                                        
                                            Article:
                                            Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS)
                                            February 2014
                                        
                                        
                                        
                                            Article:
                                            the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate)
                                            June 2013